One of the most ignored aspects of the COVID-19 pandemic has been the impact of public
health measures by governments on wider health and welfare. From March 2020, hospitals …

Background Since a national lockdown was introduced across the UK in March, 2020, in
response to the COVID-19 pandemic, cancer screening has been suspended, routine …

Background Several countries have reported a decline in cancer diagnoses during the
COVID-19 pandemic [Citation 1–7]. The European Cancer Organisation estimated that …

Background The restructuring of healthcare systems to cope with the demands of the COVID-
19 pandemic has led to a reduction in clinical services such as cancer screening and …

Background The COVID-19 pandemic was managed in Aotearoa New Zealand (NZ) by a
COVID-19 elimination policy, involving border closure and an initial national lockdown. This …

Background Changes in the management of patients with cancer and delays in treatment
delivery during the COVID-19 pandemic may impact the use of hospital resources and …

This paper outlines the impact of the COVID-19 pandemic on cancer services in the UK
including screening, symptomatic diagnosis, treatment pathways and projections on clinical …

Screening and early symptom-based detection of cancer offer the prospect of diagnosing
cancers at a stage where treatment can lead to either prolonged survival or cure. While …

Following the first case of acute respiratory syndrome coronavirus 2 (SARS-CoV-2, known
as COVID-19) in Denmark at the end of February 2020, wide-spread social distancing was …

Background The coronavirus disease COVID-19 pandemic posed a number of challenges to
the oncology community, particularly the diagnosis and care of cancer patients while …